134 related articles for article (PubMed ID: 15796261)
1. Presentation of prostate carcinoma with cervical lymphadenopathy: report of three cases.
Wang HJ; Chiang PH; Peng JP; Yu TJ
Chang Gung Med J; 2004 Nov; 27(11):840-4. PubMed ID: 15796261
[TBL] [Abstract][Full Text] [Related]
2. [A case of prostatic adenocarcinoma clinically presenting as supraclavicular and mediastinal lymphadenopathy].
Tsujino K; Sasada S; Kawahara K; Terada H; Komori C; Suzuki H; Okamoto N; Kobayashi M; Hirashima T; Matsui K; Kawase I
Nihon Kokyuki Gakkai Zasshi; 2007 Aug; 45(8):648-53. PubMed ID: 17763696
[TBL] [Abstract][Full Text] [Related]
3. Fine needle aspiration biopsy diagnosis of metastatic prostate carcinoma to inguinal lymph node.
Rosa M; Chopra HK; Sahoo S
Diagn Cytopathol; 2007 Sep; 35(9):565-7. PubMed ID: 17703448
[TBL] [Abstract][Full Text] [Related]
4. Incidence of positive pelvic lymph nodes in patients with prostate cancer, a prostate-specific antigen (PSA) level of < or =10 ng/mL and biopsy Gleason score of < or =6, and their influence on PSA progression-free survival after radical prostatectomy.
Weckermann D; Goppelt M; Dorn R; Wawroschek F; Harzmann R
BJU Int; 2006 Jun; 97(6):1173-8. PubMed ID: 16686707
[TBL] [Abstract][Full Text] [Related]
5. Cervical lymph node enlargement on the right side as the initial manifestation of metastatic prostate cancer.
Ozgür A; Ilker Y; Türkeri LN
Arch Esp Urol; 2003 Sep; 56(7):859-61. PubMed ID: 14595895
[TBL] [Abstract][Full Text] [Related]
6. Ovarian serous tumors of low malignant potential with nodal low-grade serous carcinoma.
Djordjevic B; Malpica A
Am J Surg Pathol; 2012 Jul; 36(7):955-63. PubMed ID: 22613998
[TBL] [Abstract][Full Text] [Related]
7. A surprising diagnosis: metastatic prostate cancer causing cervical lymphadenopathy.
Lad M; Sharma A; Patten DK
BMJ Case Rep; 2014 Feb; 2014():. PubMed ID: 24518391
[TBL] [Abstract][Full Text] [Related]
8. Metastatic prostate carcinoma presenting as supraclavicular lymphadenopathy - is it unusual?
Ahamed SH; Agarwal AK; Raju PP
Ann R Coll Surg Engl; 2006 Oct; 88(6):W4-5. PubMed ID: 17059705
[TBL] [Abstract][Full Text] [Related]
9. Robotic extended pelvic lymphadenectomy for intermediate- and high-risk prostate cancer.
Yuh BE; Ruel NH; Mejia R; Wilson CM; Wilson TG
Eur Urol; 2012 May; 61(5):1004-10. PubMed ID: 22366188
[TBL] [Abstract][Full Text] [Related]
10. Supraclavicular lymph node: incidence of unsuspected metastatic prostate cancer.
Hematpour K; Bennett CJ; Rogers D; Head CS
Eur Arch Otorhinolaryngol; 2006 Sep; 263(9):872-4. PubMed ID: 16830117
[TBL] [Abstract][Full Text] [Related]
11. Prostatic adenocarcinoma presenting as isolated inguinal lymphadenopathy.
Doreswamy K; Karthikeyan VS; Nagabhushana M; Shankaranand B
BMJ Case Rep; 2015 Jul; 2015():. PubMed ID: 26153290
[TBL] [Abstract][Full Text] [Related]
12. Prostate adenocarcinoma manifesting as generalized lymphadenopathy.
Moura FM; Garcia LT; Castro LP; Ferrari TC
Urol Oncol; 2006; 24(3):216-9. PubMed ID: 16678051
[TBL] [Abstract][Full Text] [Related]
13. Transforming growth factor-beta 1: comparative immunohistochemical localization in human primary and metastatic prostate cancer.
Eastham JA; Truong LD; Rogers E; Kattan M; Flanders KC; Scardino PT; Thompson TC
Lab Invest; 1995 Nov; 73(5):628-35. PubMed ID: 7474936
[TBL] [Abstract][Full Text] [Related]
14. Detecting lymph nodes metastasis in prostate cancer through extended vs. standard laparoscopic pelvic lymphadenectomy.
Arenas LF; Füllhase C; Boemans P; Fichtner J
Aktuelle Urol; 2010 Jan; 41 Suppl 1():S10-4. PubMed ID: 20094944
[TBL] [Abstract][Full Text] [Related]
15. Phase I-II trial evaluating combined intensity-modulated radiotherapy and in situ gene therapy with or without hormonal therapy in treatment of prostate cancer-interim report on PSA response and biopsy data.
Teh BS; Ayala G; Aguilar L; Mai WY; Timme TL; Vlachaki MT; Miles B; Kadmon D; Wheeler T; Caillouet J; Davis M; Carpenter LS; Lu HH; Chiu JK; Woo SY; Thompson T; Aguilar-Cordova E; Butler EB
Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1520-9. PubMed ID: 15050332
[TBL] [Abstract][Full Text] [Related]
16. Prediction of pelvic lymph node metastasis by the ratio of cathepsin B to stefin A in patients with prostate carcinoma.
Sinha AA; Quast BJ; Wilson MJ; Fernandes ET; Reddy PK; Ewing SL; Gleason DF
Cancer; 2002 Jun; 94(12):3141-9. PubMed ID: 12115346
[TBL] [Abstract][Full Text] [Related]
17. Does the molecular staging in pelvic lymph nodes improve the detection of relevant prostate cancer metastases? An assessment after 6 years.
Schostak M; Krause H; Miller K; Schrader M; Kempkensteffen C; Kollermann J
BJU Int; 2007 Jun; 99(6):1409-14. PubMed ID: 17428244
[TBL] [Abstract][Full Text] [Related]
18. Perineural invasion and seminal vesicle involvement predict pelvic lymph node metastasis in men with localized carcinoma of the prostate.
Stone NN; Stock RG; Parikh D; Yeghiayan P; Unger P
J Urol; 1998 Nov; 160(5):1722-6. PubMed ID: 9783940
[TBL] [Abstract][Full Text] [Related]
19. Lymphatic spread of nodal metastases in high-risk prostate cancer: The ascending pathway from the pelvis to the retroperitoneum.
Briganti A; Suardi N; Capogrosso P; Passoni N; Freschi M; di Trapani E; Gallina A; Capitanio U; Abdollah F; Tutolo M; Bianchi M; Salonia A; Da Pozzo LF; Montorsi F; Rigatti P
Prostate; 2012 Feb; 72(2):186-92. PubMed ID: 21538428
[TBL] [Abstract][Full Text] [Related]
20. Clinico-pathologic characterisation of metastatic prostate cancer in the Radiotherapy and Oncology Department, Ahmadu Bello University Teaching Hospital, Zaria-Nigeria: 2006-2009.
Adewuyi SA; Mbibu NH; Samaila MO; Ketiku KK; Durosinmi-Etti FA
Niger Postgrad Med J; 2013 Mar; 20(1):45-51. PubMed ID: 23661210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
